IDEAYA Biosciences, Inc.
IDYA
$30.24
$0.391.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 11.81% | 4.71% | |||
| Gross Profit | 268.19% | -4.71% | |||
| SG&A Expenses | 12.41% | 7.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.91% | 5.23% | |||
| Operating Income | 222.12% | -5.23% | |||
| Income Before Tax | 253.88% | -7.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 253.88% | -7.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 253.88% | -7.36% | |||
| EBIT | 222.12% | -5.23% | |||
| EBITDA | 223.87% | -5.13% | |||
| EPS Basic | 253.78% | -7.22% | |||
| Normalized Basic EPS | 253.80% | -7.21% | |||
| EPS Diluted | 251.84% | -7.22% | |||
| Normalized Diluted EPS | 251.79% | -7.21% | |||
| Average Basic Shares Outstanding | 0.06% | 0.13% | |||
| Average Diluted Shares Outstanding | 1.38% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||